Stockscreener 앱 받기
27.55
1.68%
0.455
시간 외 거래:
26.97
-0.575
-2.09%
Structure Therapeutics Inc Adr 주식(GPCR)의 최신 뉴스
Structure Therapeutics (NASDAQ:GPCR) Research Coverage Started at Citigroup - Defense World
Structure Therapeutics Inc ADR (GPCR) expanding its growth trajectory ahead - Sete News
Buy Recommendation for Structure Therapeutics: Promising Pipeline and Obesity Treatment Market Potential - TipRanks
Citi sets Structure Therapeutics stock Buy rating, $60 target By Investing.com - Investing.com India
Technical analysis of Stoke Therapeutics Inc (STOK) stock chart patterns - uspostnews.com
Terns Pharmaceuticals Inc (TERN) deserves deeper analysis - uspostnews.com
A stock that deserves closer examination: Structure Therapeutics Inc ADR (GPCR) - uspostnews.com
What is the investor’s view on LSB Industries, Inc (LXU)? - uspostnews.com
Geode Capital Management LLC Increases Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
The Potential Rise in the Price of Structure Therapeutics Inc ADR (GPCR) following insiders activity - knoxdaily.com
A Guide To The Risks Of Investing In Jamf Holding Corp (JAMF) - knoxdaily.com
GPCR Stock: A Voyage Through Structure Therapeutics Inc ADR’s Finances - investchronicle.com
Recent Insider Activity Could Benefit Pacific Premier Bancorp, Inc (PPBI) - knoxdaily.com
Barclays PLC Increases Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
24,530 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Acquired by Mariner LLC - Defense World
Market Update: CytomX Therapeutics Inc (CTMX) Sees Negative Movement, Closing at 0.71 - DWinneX
Stock Market Recap: Barrick Gold Corp (GOLD) Concludes at 19.30, a 1.31 Surge/Decline - DWinneX
Market Resilience: ReShape Lifesciences Inc (RSLS) Finishes Weak at 0.36, Down -0.85 - DWinneX
Gaining Ground: Structure Therapeutics Inc ADR (GPCR) Closes Lower at 23.62, Down -0.51 - DWinneX
JPMorgan Chase & Co. Has $876,000 Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
Structure Therapeutics Inc. (NASDAQ:GPCR) Shares Acquired by LPL Financial LLC - Defense World
LPL Financial LLC Has $341,000 Stock Holdings in AdvisorShares Dorsey Wright FSM All Cap World ETF (NASDAQ:DWAW) - American Banking and Market News
Is Structure Therapeutics Inc. (NASDAQ:GPCR) the Most Promising Small-Cap Stock According to Analysts? - Yahoo Finance
Is Edgewise Therapeutics Inc. (NASDAQ:EWTX) the Most Promising Small-Cap Stock According to Analysts? - Yahoo Finance
Structure Therapeutics’ (GPCR) “Buy” Rating Reiterated at HC Wainwright - Defense World
Daily Progress: Structure Therapeutics Inc ADR (GPCR) Drop -11.51, Closing at 21.03 - DWinneX
Metric Analysis: Silvercorp Metals Inc (SVM)’s Key Ratios in the Limelight - DWinneX
Ratios Revealed: Decoding Structure Therapeutics Inc ADR (GPCR)’s Financial Health - DWinneX
Invesco Ltd. Grows Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
A Guide To The Risks Of Investing In Structure Therapeutics Inc ADR (GPCR) - knoxdaily.com
How should investors view Nano X Imaging Ltd (NNOX)? - uspostnews.com
Complete Solaria Inc (CSLR) produces promising results - uspostnews.com
Buy Rating for Structure Therapeutics: Aleniglipron’s Competitive Edge in the Oral GLP-1 Market - TipRanks
Russell Investments Group Ltd. Purchases 2,888 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
Structure Therapeutics Inc. (NASDAQ:GPCR) Receives $81.29 Average Target Price from Brokerages - Defense World
LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study - Zacks Investment Research
What Are You Thinking About Investing In Structure Therapeutics Inc ADR (NASDAQ: GPCR) Stock? - Stocksregister
Analysts’ Top Healthcare Picks: Evolent Health (EVH), Gilead Sciences (GILD) - The Globe and Mail
JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics - Yahoo Finance
Bank of Montreal Can Acquires 3,671 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - American Banking and Market News
NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback - Zacks Investment Research
Structure Therapeutics Inc ADR (NASDAQ: GPCR) Stock: A Value Hunter’s Investment? - stocksregister.com
Structure Therapeutics shares rise on Pfizer’s obesity drug exit By Investing.com - Investing.com Canada
Structure Therapeutics shares rise on Pfizer’s obesity drug exit - Investing.com
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today - The Motley Fool
Layoff Tracker: Opthea Slashes 65% of Staff, Pfizer Cuts 56 - BioSpace
Analysts’ Top Healthcare Picks: BridgeBio Pharma (BBIO), Praxis Precision Medicines (PRAX) - The Globe and Mail
What is Iterum Therapeutics Plc (ITRM) Stock Return on Shareholders’ Capital? - Sete News
ORN Stock Sees Decline of Approximately -9.53% in Last Five Days - knoxdaily.com
Quantum Corp’s Banking’s 100-Day Moving Average at 21.57: Will the Stock Break Through? - investchronicle.com
Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Apellis Pharmaceuticals (APLS) - The Globe and Mail
Cognito Therapeutics Announces Spectris™ Data Demonstrating Brain Structural Maintenance and Mechanism of Action in Alzheimer’s Disease at AD/PD™ 2025 - Business Wire
Predicting Upstart Holdings Inc’s (UPST) earnings for the current quarter - uspostnews.com
BIAF: Riding the Market Waves of Growth and Decline in 2023 - investchronicle.com
GPCR stock touches 52-week low at $19.29 amid market challenges - Investing.com Canada
Analysts Set Structure Therapeutics Inc. (NASDAQ:GPCR) PT at $81.29 - Defense World
Cognito Therapeutics to Present New Data on Spectris’™ Impact on Brain Structure in Alzheimer’s Disease at AD/PD 2025 - Business Wire
Structure Therapeutics CEO on latest GLP-1 developments - CNBC
Oral Proteins and Peptides Market Know the Scope and Trends As Revealed In New Report - WhaTech
A new biotech licensing Chinese drugs with a unique approach gets high-profile backing - statnews.com
Analysts Are Bullish on Top Healthcare Stocks: Quanterix (QTRX), Xoma (XOMA) - The Globe and Mail
Acute Bacterial Skin and Skin-Structure Infection Market - openPR
Jones Financial Companies Lllp Raises Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
Structure Therapeutics Inc. (NASDAQ:GPCR) Shares Bought by Assetmark Inc. - Defense World
0.39%
3.66%
자본화:
|
볼륨(24시간):